5-环丁基-5-苯基乙内酰脲，CAS 登记号 125650-44-4，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 5-环丁基-5-苯基乙内酰脲 的 CAS 号：125650-44-4，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
5-Cyclobutyl-5-phenylhydantoin · CAS 125650-44-4 · C13H14N2O2. UNII ST50409659.
| CAS Registry Number | 125650-44-4 |
|---|---|
| PubChem CID | 277170 |
| Molecular formula | C13H14N2O2 |
| IUPAC name | 5-cyclobutyl-5-phenylimidazolidine-2,4-dione |
| UNII (FDA) | ST50409659 |
| Molecular Weight | 230.26 |
|---|---|
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 230.105527694 |
| Monoisotopic Mass | 230.105527694 |
| Topological Polar Surface Area | 58.2 |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (100%), H319 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
5-Cyclobutyl-5-phenylhydantoin; 125650-44-4; RefChem:535103; 654-796-5; 5-cyclobutyl-5-phenylimidazolidine-2,4-dione; 2,4-Imidazolidinedione, 5-cyclobutyl-5-phenyl-; NSC125690; 5-cyclobutyl-5-phenyl-imidazolidine-2,4-dione; Oprea1_235024; Hydantoin 5-Cyclobutyl 5-Phenyl; DTXSID40925203; AKOS024319130; CCG-236871; NSC-125690; AS-76134; DB-041801
CAS 125650-44-4; molecular formula C13H14N2O2; molecular weight — g/mol.
5-Cyclobutyl-5-phenylhydantoin, 125650-44-4, RefChem:535103, 654-796-5, 5-cyclobutyl-5-phenylimidazolidine-2,4-dione, 2,4-Imidazolidinedione, 5-cyclobutyl-5-phenyl-.
Hazard statements reported: H302, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.